Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021.

ABSTRACT:

Background

Access to effective treatment for major depressive disorder remains limited and difficult to track across place and time. We analysed the available data on minimally adequate treatment (MAT) for major depressive disorder globally with the aim of providing a useful metric against which to monitor national responses to the growing public health burden imposed by major depressive disorder.

Methods

MAT was defined as pharmacotherapy (1 month of medication, plus four visits to a medical doctor) or psychotherapy (eight visits with any professional). From existing reviews, we identified mental health surveys that assessed major depressive disorder within the general population as well as health service uptake by individuals with major depressive disorder. Data by ethnici

SUBMITTER: Santomauro DF 

PROVIDER: S-EPMC11579305 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature